IP Library Granted Patent US 9,138,523
Granted Patent B2
US 9,138,523 · App. 13/473,516 · Granted Sep 22, 2015

Dialysis implant and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,523
App. No.
13/473,516
Granted
Sep 22, 2015
Kind
B2
Abstract

A device and methods for treating renal failure are disclosed. One embodiment of the device is an implantable peritoneal dialysis device. When in use, the device can have a semi-permeable reservoir implanted in the peritoneal cavity. The reservoir can receive blood waste and drain through one or more conduits, via a pump, to the biological bladder. Solids and/or a solution benefiting dialysis can be pumped to the reservoir and/or implanted in the peritoneal cavity.

Claims (34)

1. A peritoneal dialysis system comprising:

a reservoir containing dialysate comprising an osmotic agent for infusion into a peritoneal cavity;

an implantable pump having an internal battery that is inductively chargeable, the implantable pump adapted for fluidic communication with the peritoneal cavity and a bladder;

a drainage conduit adapted for coupling between the peritoneal cavity and the implantable pump;

an exit conduit adapted for coupling between the bladder and the implantable pump, wherein the implantable pump is configured to pump the dialysate comprising the osmotic agent from the peritoneal cavity through the drainage conduit into the bladder through the exit conduit; and

an implantable controller associated with the implantable pump, the implantable controller including a clock and configured to actuate the implantable pump to meter movement of the dialysate between the peritoneal cavity and the bladder based on an output of the clock.

2. The system of claim 1 , wherein the implantable controller is configured to monitor a difference in pressure between the peritoneal cavity and the bladder.

3. The system of claim 1 , wherein the implantable controller is configured to communicate data to an external controller.

4. The system of claim 1 , wherein the implantable controller is configured to monitor a physiologic parameter, the controller programmed to adjust a rate at which the dialysate is pumped between the peritoneal cavity and the bladder responsive to a value of the monitored physiologic parameter.

5. The system of claim 1 , further comprising an inductive recharging circuit for recharging the internal battery.

6. The system of claim 1 , wherein the drainage conduit comprises a semi-permeable conduit.

7. The system of claim 1 , further comprising an anchor attached to the exit conduit, the anchor being configured to anchor an end of the exit conduit within the bladder.

8. The system of claim 4 , wherein the monitored physiological parameter comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the peritoneal cavity sensed using a peritoneal sensor.

9. The system of claim 4 , wherein the monitored physiological parameter comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the bladder sensed using a bladder sensor.

10. The system of claim 1 , wherein the reservoir for use with the system is adapted for implantation.

11. A method of performing peritoneal dialysis on a subject having a peritoneal cavity and a bladder, the method comprising:

implanting a battery powered, inductively rechargeable pump within the subject;

introducing a dialysate comprising an osmotic agent into the peritoneal cavity from a reservoir;

pumping the dialysate from the peritoneal cavity into the bladder using the pump;

monitoring an output of a clock using an implantable controller associated with the pump; and

adjusting a rate at which the dialysate is pumped between the peritoneal cavity and the bladder responsive to the output of the clock.

12. The method of claim 11 , further comprising implanting the reservoir in the peritoneal cavity.

13. The method of claim 11 , wherein introducing the dialysate comprises introducing the dialysate into the peritoneal cavity from the reservoir through a reservoir conduit.

14. The method of claim 11 , wherein introducing the dialysate comprises introducing the dialysate into the peritoneal cavity from the reservoir through a reservoir conduit and a discharge conduit using a second pump,

wherein the reservoir conduit is coupled between the reservoir and the second pump and the discharge conduit is adapted for coupling between the second pump and the peritoneal cavity.

15. The method of claim 11 , wherein pumping the dialysate comprises pumping the dialysate from the peritoneal cavity through a drainage conduit into the bladder through an exit conduit,

wherein the drainage conduit is adapted for coupling between the peritoneal cavity and the pump and the exit conduit is adapted for coupling between the pump and the bladder.

16. The method of claim 11 , further comprising monitoring a condition of the peritoneal cavity sensed by a peritoneal sensor operatively coupled to the implantable controller associated with the pump, and

adjusting the rate at which the dialysate is pumped between the peritoneal cavity and the bladder responsive the sensed condition of the peritoneal cavity.

17. The method of claim 16 , wherein the sensed condition of the peritoneal cavity comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the peritoneal cavity.

18. The method of claim 11 , further comprising monitoring a condition of the bladder sensed by a bladder sensor operatively coupled to the implantable controller associated with the pump, and

adjusting the rate at which the dialysate is pumped between the peritoneal cavity and the bladder responsive to the sensed condition of the bladder.

19. The method of claim 18 , wherein the sensed condition of the bladder comprises pressure, pH, temperature, electrolyte concentration, analyte concentration, or any combination thereof of the bladder.

20. The method of claim 11 , further comprising inductively recharging the battery of the pump.

Assignments (10)
SECURITY INTEREST Recorded Feb 27, 2025
From: DSRCO BV
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 070356/0934 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2025
From: SEQUANA MEDICAL NV
To: DSRCO BV
Reel/Frame 070308/0171 →
SECURITY INTEREST Recorded Sep 25, 2024
From: SEQUANA MEDICAL NV
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 069049/0129 →
RELEASE OF SECURITY INTEREST Recorded Jul 31, 2020
From: BOOTSTRAP EUROPE S.C.SP.
To: SEQUANA MEDICAL NV
Reel/Frame 053375/0176 →
CHANGE OF NAME Recorded Jun 9, 2019
From: SEQUANA MEDICAL AG
To: SEQUANA MEDICAL NV
Reel/Frame 049414/0245 →
SECURITY INTEREST Recorded Sep 28, 2016
From: SEQUANA MEDICAL AG
To: BOOTSTRAP EUROPE S.C.SP.
Reel/Frame 039884/0368 →
CHANGE OF NAME Recorded Apr 10, 2014
From: NOVASHUNT AG
To: SEQUANA MEDICAL AG
Reel/Frame 032660/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: NOVASHUNT, INC.
To: NOVASHUNT AG
Reel/Frame 032650/0408 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: THERANOVA, LLC
To: NOVASHUNT, INC.
Reel/Frame 032650/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2014
From: BURNETT, DANIEL R; HALL, GREGORY W
To: THERANOVA, LLC
Reel/Frame 032650/0232 →